RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Do soaps with triclosan do more harm than good?

    Do soaps with triclosan do more harm than good?
    If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection. But some scientists are increasingly concerned that a common anti-bacterial ingredient called triclosan...
  • Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
  • Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...
  • EU advises all girls need cervical cancer vaccines

    EU advises all girls need cervical cancer vaccines
    LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...
  • Dangerous pharmaceuticals marketed as supplements

    Dangerous pharmaceuticals marketed as supplements
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...
  • AIDS deaths worldwide drop as access to drugs improves

    AIDS deaths worldwide drop as access to drugs improves
    LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday. The United Nations...
  • Saving lives one step at a time

    Saving lives one step at a time
    For years people around the country have been climbing mountains for CureDuchenne. As they raise money and awareness, they also get younger. Most recently, 8-year-old Tyler Armstrong climbed Mt. Kilimanjaro and helped raise about $40,000 for the Newport...
  • GlaxoSmithKline to acquire Human Genome Sciences

    GlaxoSmithKline to acquire Human Genome Sciences
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...
  • Report: Dr. Drew Paid $275K to Promote Antidepressant

    Report: Dr. Drew Paid $275K to Promote Antidepressant
    LOS ANGELES (KTLA) -- Celebrity addiction specialist Dr. Drew Pinsky is under fire for helping market an antidepressant for uses not approved by the Food and Drug Administration. GlaxoSmithKline, which makes the drug Wellbutrin, agreed to pay a $3...